Table 2.
Gender-specific summary of cancer risk for each 5 kg per m2 increase in BMI for major cancers with strong evidence of relationship with obesity.
| Type of Cancer | Number of Cohorts | Relative Risk (95% Confidence Interval) | |
|---|---|---|---|
| Women | Men | ||
| Endometrial cancer [4] | 19 | 1.59 (1.50–1.68) | NA |
| Gallbladder cancer [4] | 4 | 1.59 (1.02–2.47) | 1.09 (0.99–1.21) |
| Esophageal adenocarcinoma [4] | 5 | 1.51 (1.31–1.74) | 1.52 (1.33–1.74) |
| Kidney cancer [4] | 12 | 1.34 (1.25–1.43) | 1.24 (1.15–1.34) |
| Postmenopausal breast cancer [4] | 34 | 1.12 (1.08–1.16) | NA |
| Hpatocellular cancer [19] | 9 | 1.12 (1.03–1.22) | 1.19 (1.09–1.29) |
| Pancreatic adenocarcinoma [23] | 23 | 1.10 (1.04–1.16) | 1.13 (1.04–1.22) |
| Colon cancer [4] | 29 | 1.09 (1.05–1.13) | 1.24 (1.20–1.28) |
| Ovarian cancer [77] | 34 | 1.06 (1.00–1.12) | NA |
| Stomach cancer [4] | 8 | 1.04 (0.90–1.20) | 0.97 (0.88–1.06) |
| Rectal cancer [4] | 29 | 1.02 (1.00–1.05) | 1.09 (1.06–1.12) |
| Later stage prostate cancer [73] | 23 | NA | 1.08 (1.04–1.12) |
NA = not available.